Scipio Bioscience

Scipio Bioscience
Scipio Bioscience
STRAIGHTFORWARD SINGLE-CELL PROFILING AT YOUR FINGERTIPS
A powerful benchtop kit to extract mRNA from single cells anytime, anywhere.
Addressing the current issues with ScRNA-seq
ScRNA-seq is an exciting approach already delivering groundbreaking results, but its accessibility still has a long way to go to become an easy, well-established, and robust assay for everyone. Substantial RNA degradation due to lengthy preparation steps, the sometimes low availability of high-throughput instruments and the resulting tight planning leaving little flexibility for treating precious samples are but a few issues preventing ScRNA-seq to become routinely used.
Paris
RNA, robust, Bioscience
Between €5 million-€10 million
2017
https://scipio.bio/
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Scipio Bioscience? We’re happy to assist you with our Startup Sourcing service.